The European Union’s drug regulator on Friday said it is recommending adding “heavy menstrual bleeding” as a side effect to both Pfizer’s and Moderna’s COVID-19 vaccines, according to an advisory panel meeting.
The European Medicines Agency (EMA) today recommended adding a warning for two types of heart inflammation to Novavax’s COVID-19 vaccine, marketed under the brand names Nuvaxovid and Covovax, based on a small number of cases reported in those who received the vaccine.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,350,950 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and July 15, 2022, to the Vaccine Adverse Event Reporting System (VAERS).
A final hearing began today in the investigation into the death of a 26-year-old man who died last year from “catastrophic” blood clots in his brain 13 days after receiving the AstraZeneca COVID-19 vaccine.
